{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:28Z","timestamp":1758588148958,"version":"3.44.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.transproceed.2019.03.078","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T20:12:57Z","timestamp":1569442377000},"page":"2624-2628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Trough Level of Mycophenolic Acid Did Not Affect De Novo DSA Development in Kidney Transplantation"],"prefix":"10.1016","volume":"51","author":[{"given":"Noriyuki","family":"Masaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Iwadoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Tonsho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Fuchinoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2019.03.078_bib1","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1681\/ASN.2016070797","article-title":"Antibody-mediated rejection due to preexisting versus de novo donor-specific antibodies in kidney allograft recipients","volume":"28","author":"Aubert","year":"2017","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.03.078_bib2","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.03.078_bib3","first-page":"163","article-title":"Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss","volume":"9","author":"Everly","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2019.03.078_bib4","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/TP.0000000000000958","article-title":"One-year results of the effects of rituximab on acute antibody-mediated rejection in renal transplantation: RITUX ERAH, a multicenter double-blind randomized placebo-controlled trial","volume":"100","author":"Sautenet","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2019.03.078_bib5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0162-3109(00)00190-9","article-title":"The use of mycophenolate mofetil in transplant recipients","volume":"47","author":"Mele","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.transproceed.2019.03.078_bib6","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1681\/ASN.2011010006","article-title":"Randomized trial of immunosuppressive regimens in renal transplantation","volume":"22","author":"Guerra","year":"2011","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.03.078_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0012.2007.00739.x","article-title":"Calcineurin inhibitor-sparing regimens in solid organ transplantation: focus on improving renal function and nephrotoxicity","volume":"22","author":"Flechner","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2019.03.078_bib8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.12659\/AOT.895104","article-title":"Tacrolimus trough levels as a risk factor for acute rejection in renal transplant patients","volume":"21","author":"Arreola-Guerra","year":"2016","journal-title":"Ann Transplant"},{"key":"10.1016\/j.transproceed.2019.03.078_bib9","unstructured":"Iwadoh K, Ogawa Y, Miki K, et\u00a0al. Tacrolimus kettyunoudo no isyokujinnkinou ya DSA heno eikyo [Tacrolimus blood concentration influenced graft function and DSA in kidney transplantation]. Paper presented at: 51st Annual Congress of the Japanese Society for Clinical Renal Transplantation. February 14-16, 2018. Kobe, Japan."},{"key":"10.1016\/j.transproceed.2019.03.078_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2215\/CJN.07111009","article-title":"Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation","volume":"5","author":"Kuypers","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.03.078_bib11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.clinthera.2008.04.014","article-title":"Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients","volume":"30","author":"Kuypers","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.transproceed.2019.03.078_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/petr.12637","article-title":"Minimum mycophenolic acid levels are associated with donor-specific antibody formation","volume":"20","author":"Filler","year":"2016","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.transproceed.2019.03.078_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1681\/ASN.2005101070","article-title":"Explaining variability in mycophenolic acid exposure to optimize mycophenolate mofetil dosing: a population pharmacokinetic meta-analysis of mycophenolic acid in renal transplant recipients","volume":"17","author":"Van Hest","year":"2006","journal-title":"J\u00a0Am Soc Nephrol"},{"key":"10.1016\/j.transproceed.2019.03.078_bib14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/FTD.0b013e31818b8244","article-title":"Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation","volume":"30","author":"Mino","year":"2008","journal-title":"Ther Drug Monit"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518313939?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134518313939?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:31:20Z","timestamp":1758576680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134518313939"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0041134518313939"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.03.078","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trough Level of Mycophenolic Acid Did Not Affect De Novo DSA Development in Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2019.03.078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}